AREXMIS (AREXMIS) Fair Value & Analysis

IN · Market cap ₹768M

A AREXMIS AREXMIS · BSE

Price₹112.00

Fair Value₹43.19

Upside-61.4%

Quality45/100

Watch AREXMIS for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range ₹32.39 – ₹53.99

Fair value as of: Jul 5, 2026

From 24 valuation models · updated today

Share price −1.4% over the past month.

Price vs Fair Value (12 months)

12‑month range ₹95.50 – ₹159.00 · fair‑value band ₹32.39 – ₹53.99 · the ₹112.00 price screens above the ₹43.19 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

AREXMIS (AREXMIS) currently trades at ₹112.00, while our model-based Fair Value estimate is ₹43.19 — implying the stock looks roughly 61.4% overvalued today. We read business quality at 45/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, AREXMIS generated revenue of ₹496M at a net margin of 3.0%. Revenue declined 2.1% year over year. It earns a return on equity of 5.6%. Net debt stands at ₹105M. Fundamentals as of Jul 5, 2026

Key figures & financial health

Revenue (TTM) ₹496M

Revenue growth (YoY) -2.1%

Net margin 3.0%

Return on equity 5.6%

Free cash flow ₹27.0M FY2026

P/E ratio 27.2

More key figures

Operating margin 1.9%

EPS (TTM) ₹4.12

EPS growth (YoY) -73.5%

Net debt ₹105M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

AREXMIS reported revenue of ₹496M in FY2026 versus ₹538M in FY2022, a compound −2.0%/yr. Reported net income was ₹14.8M in FY2026, compounding −20.4%/yr from FY2022.

Revenue −2.0%/yr

FY22 ₹538M

FY23 ₹450M

FY24 ₹510M

FY25 ₹511M

FY26 ₹496M

Net income −20.4%/yr

FY22 ₹37.0M

FY23 ₹7.0M

FY24 ₹25.4M

FY25 ₹26.3M

FY26 ₹14.8M

Is AREXMIS fairly valued? → Check now

Explore undervalued stocks

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is AREXMIS (AREXMIS) undervalued?

As of Jul 5, 2026, our model estimates a fair value of ₹43.19 versus a price of ₹112.00 — about −61% (overvalued). Model-based estimate, not financial advice.

What is the fair value of AREXMIS?

Our model-based fair value for AREXMIS is ₹43.19 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹112.00.

What is the quality score of AREXMIS?

AREXMIS has a Quality Score of 45/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of AREXMIS (AREXMIS)?

AREXMIS reported trailing-twelve-month revenue of about ₹496M (latest available figure, as of Jul 5, 2026).

What is the net profit margin of AREXMIS?

The net profit margin of AREXMIS is about 3.0%, meaning it keeps roughly 3.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.